Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SENEB vs HLF: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SENEB Captures Overall Composite Edge (54.4 HOLD vs 35.4 SELL), While HLF Leads 5–1 on Growth & Valuation Pillars

SENEB Overall Winner 6-Pillar Tally: SENEB 1 – 5 HLF Matrix Metrics: SENEB 5 – 5 HLF

As of Nov 16, 2026, SENEB (SENEB) captures the overall head-to-head institutional edge over Herbalife Ltd. (HLF) on higher Unified Composite conviction (54.4/100 HOLD vs. 35.4/100 SELL) after splitting the core matrix 5–5 (led by Balance Sheet & Cash Flow), while HLF wins 5–1 across the 6-pillar growth and valuation breakdown. SENEB trades at $170.26 (48.1x Forward P/E, 8.9% operating margin) versus HLF at $16.15 (5.3x Forward P/E, 9.8% operating margin).

  • Growth vs. Quality Trade-Off: SENEB earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. HLF 35.4/100 SELL) and 0.10β · 88% Vol risk profile, whereas HLF leads top-line expansion (+6.0% YoY revenue growth, 0.61x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SENEB vs HLF
SENEB US Equity Head-to-Head Winner
SENEB
Institutional Equity
$170.26
-1.47% 1D
Market Cap $1.2B
TTM Revenue $1.80B
Forward P/E 48.1x
Beta / 30D Vol 0.10β · 88% Vol
Unified Composite Score
54.4 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
HLF NYSE
Herbalife Ltd.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$16.15
+1.19% 1D
Market Cap $1.7B
TTM Revenue $5.28B
Forward P/E 5.3x
Beta / 30D Vol 1.06β · 47% Vol
Unified Composite Score
35.4 / 100 SELL
Tech 50.0 Fund 30.0 Flow 59.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.2% over 20 days), RSI 70
RSI-14: 70.4 · SMA20: $14.40 · SMA50: $13.37

6-Pillar Scorecard Institutional Category Breakdown (SENEB 1 – 5 HLF)

Columns: Metric · SENEB · HLF
1. Valuation Multiples HLF
Forward P/E 48.1x 5.3x
Trailing P/E 10.0x 9.4x
PEG Ratio 0.94x 0.61x
EV / Revenue 0.6x 0.6x
2. Growth & Scale HLF
Revenue Growth (YoY) +7.1% +6.0%
Earnings Growth (YoY) -0.4% +31.5%
TTM Revenue (USD) $1.80B $5.28B
Market Cap $1.2B $1.7B
3. Profitability & Quality HLF
Gross Margin 13.2% 77.6%
Operating Margin 8.9% 9.8%
Net Profit Margin 6.6% 3.4%
Return on Equity (ROE) 16.1% 0.0%
4. Balance Sheet & Cash Flow SENEB
Cash Generation (TTM) $202M EBITDA $337M
Cash Flow Margin 11.2% EBITDA Mgn 6.4%
Net Cash / Leverage $118.44 Book/Sh · 16.1% ROE $1.70B Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HLF
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile N/A (N/A) 58.5% (5th %ile)
Put/Call OI Skew N/A 0.21x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat HLF
OpEx & R&D Intensity 4.3% of Rev ($77M) 67.8% of Rev ($3.58B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SENEB (5) vs HLF (5)
Institutional Metric SENEB HLF Criterion Row Edge
Market Capitalization
Scale
$1.2B $1.7B Larger Scale HLF
Trailing P/E Ratio
Valuation
10.0x 9.4x Lower Multiple HLF
Forward P/E Ratio
Valuation
48.1x 5.3x Lower Multiple HLF
Revenue Growth (YoY)
Growth
+7.1% +6.0% Higher Growth SENEB
Operating Margin (TTM)
Profitability
8.9% 9.8% Higher Margin HLF
Net Profit Margin
Profitability
6.6% 3.4% Higher Margin SENEB
Return on Equity (ROE)
Capital Efficiency
16.1% 0.0% Higher ROE SENEB
52-Week Range Position
Momentum
72% ($71–$209) 64% ($9–$20) Stronger Trend SENEB
Beta / 30D Volatility
Risk Regime
0.10β · 88% Vol 1.06β · 47% Vol Lower Realized Risk HLF
Unified Institutional Score
Composite Signal
54.4 / 100 (HOLD) 35.4 / 100 (SELL) Higher Composite SENEB
Trailing 12M Revenue (USD)
Operating Scale
$1.80B $5.28B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
13.2% 77.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.94x PEG · 0.6x EV/Rev 0.61x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$202M EBITDA ($118.44 Book/Sh · 16.1% ROE) $337M ($1.70B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HLF +32.97 pp
SENEB: -9.44% · HLF: +23.53%
3M Horizon SENEB +39.93 pp
SENEB: +22.71% · HLF: -17.22%
6M Horizon HLF +25.78 pp
SENEB: +43.47% · HLF: +69.25%
1Y Horizon HLF +25.78 pp
SENEB: +43.47% · HLF: +69.25%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SENEB vs HLF. Trailing 12-month operating profitability (SENEB 8.9% vs HLF 9.8%) and valuation multiples (SENEB 48.1x vs HLF 5.3x Forward P/E) are benchmarked directly in Pillar 4 below.

SENEB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.80B
Gross Margin13.2%
Op. Margin8.9%
ROE / Fwd P/E16.1% · 48.1x
HLF ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.28B
Gross Margin77.6%
Op. Margin9.8%
ROE / Fwd P/E0.0% · 5.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SENEB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SENEB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HLF SURGE
5d in phase · OBV NEUTRAL
Current IV 58.5%
IV Percentile 5th %ile
Put/Call OI Skew 0.21x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact HLF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SENEB Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $1.2B market capitalization and 8.9% operating margin.
OpEx & R&D Reinvestment 4.3% of Rev ($77M)
90D Engineering Disclosures 0 Published
HLF Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $1.7B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment 67.8% of Rev ($3.58B)
90D Engineering Disclosures 0 Published

Investor FAQ SENEB vs HLF Key Questions & Quantitative Answers

As of Nov 16, 2026, SENEB (SENEB) captures the overall head-to-head institutional edge over Herbalife Ltd. (HLF) on higher Unified Composite conviction (54.4/100 HOLD vs. 35.4/100 SELL) after splitting the core matrix 5–5 (led by Balance Sheet & Cash Flow), while HLF wins 5–1 across the 6-pillar growth and valuation breakdown. SENEB trades at $170.26 (48.1x Forward P/E, 8.9% operating margin) versus HLF at $16.15 (5.3x Forward P/E, 9.8% operating margin). Growth vs. Quality Trade-Off: SENEB earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. HLF 35.4/100 SELL) and 0.10β · 88% Vol risk profile, whereas HLF leads top-line expansion (+6.0% YoY revenue growth, 0.61x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

HLF leads the Growth & Scale pillar: SENEB posts +7.1% YoY revenue growth and -0.4% YoY earnings growth on $1.80B TTM revenue (13.2% gross margin, 8.9% operating margin), compared with HLF at +6.0% YoY revenue growth and +31.5% YoY earnings growth on $5.28B TTM revenue (77.6% gross margin, 9.8% operating margin). On trailing 12-month operating scale, SENEB generates $1.80B in USD-normalized revenue versus $5.28B for HLF. In operating R&D and SG&A reinvestment, SENEB deploys 4.3% of Rev ($77M) (0 90-day corporate R&D disclosures) versus 67.8% of Rev ($3.58B) (0 disclosures) for HLF.

HLF screens cheaper on headline valuation multiples. SENEB trades at 48.1x Forward P/E, 10.0x Trailing P/E, 0.94x PEG, and 0.6x EV/Revenue (11.2% EBITDA margin), whereas HLF trades at 5.3x Forward P/E, 9.4x Trailing P/E, 0.61x PEG, and 0.6x EV/Revenue (6.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SENEB (16.1% ROE) versus HLF (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, SENEB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.10β · 88% Vol realized risk). By comparison, HLF carries 58.5% implied volatility (5th %ile, Compressed (<25th %ile)), a 0.21x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.06β · 47% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.